Dressed exciton versus dressed atom: The space-dimension dependence.

Tanguy,Combescot

DOI: https://doi.org/10.1103/PHYSREVB.40.12562

1989-12-15

Abstract:Le changement relatif de la force d'absorption d'exiton habilles est celui de l'atome habille multipliee par 1-d pour chaque niveau exciton, d etant la dimension spatiale. Derivation analytique de ce resultat

What problem does this paper attempt to address?

Nanoporous alumina capsules for cellular macroencapsulation: transport and biocompatibility.

Kristen E. La Flamme,Gopal Mor,Dawei Gong,Thomas La Tempa,Vincent A. Fusaro,Craig A. Grimes,Tejal A. Desai

DOI: https://doi.org/10.1089/dia.2005.7.684

2005-01-01

Diabetes Technology & Therapeutics

Abstract:Background: Currently, the most widely used treatment for diabetes is the daily subcutaneous injection of recombinant human insulin. Daily injections, however, cannot match the physio- logical biphasic behavior of normal insulin release, nor can they precisely meet the demands of food intake, exercise, and stress. Cellular encapsulation, or immunoisolation, is a possible solu- tion to this problem. This cell-based therapy allows patients to receive the benefits of more phys- iological insulin and blood glucose regulation, without the need for immunosuppressants that are associated with organ or cell transplantation. Methods: Immunoisolation capsules were fabricated out of aluminum and aluminum oxide using a two-step anodization procedure. The diffusion behavior of glucose, immunoglobulin G (IgG), and insulin were measured. Furthermore, the functionality and viability of encapsulated MIN6 cells were tested. Finally, live cells were stained and imaged using confocal microscopy. Results: Data indicated that this device is effective in allowing the transport of relevant mol- ecules such as glucose and insulin, while at the same time significantly impeding the transport of IgG, suggesting that it would be efficacious in protecting cell grafts in vivo. Furthermore, en- capsulated cells were able to respond dynamically to glucose input signals. Finally, cell staining showed that the viability of encapsulated cells is maintained after 24 h, although the cells ap- pear to be more heavily concentrated at the area that is closest to the membrane. Conclusions: This study has shown that nanoporous alumina membranes, with well-con- trolled pore sizes, can be used for the encapsulation of therapeutic cells and may provide an al- ternative encapsulation strategy for the treatment of diabetes.
Activation Transcription Factor 1 Involvement in the Regulation of Murine H-2D d Expression*

N. Ishiguro,G. D. Brown,D. Meruelo

DOI: https://doi.org/10.1074/jbc.272.25.15993

IF: 5.485

1997-06-20

Journal of Biological Chemistry

Abstract:Resistance to radiation leukemia virus-induced leukemia is correlated with an increase in H-2D expression on the thymocyte surface. Recently, it has been shown that elevated H-2Dd expression on the infected thymocyte is a result of elevated mRNA transcription and that the transcriptional increase is correlated with elevated levels of a DNA binding activity, H-2 binding factor 1 (H-2 BF1), which recognizes the 5′-flanking sequences (5′-TGACGCG-3′) of the H-2D d gene. This target for transcription factor binding has been found to be identical in the 5′-regulatory region of 12 rodent class I genes, nine of which have been shown to be functional genes. Furthermore, thiscis-element is found 5′ of 20 primate class I genes (15 human genes), seven of which are known to be functional. Here, we demonstrate that activation transcription factor 1 (ATF-1) is one component of H-2 BF1. In addition, the levels of ATF-1mRNA in uninfected and radiation leukemia virus-infected thymocytes parallel those of H-2D d mRNA, and therefore, it is suggested that ATF-1 up-regulates the transcription of theH-2D d gene after radiation leukemia virus infection of thymocytes. Transfection experiments also demonstrate that ATF-1 activates a reporter plasmid that contains the H-2 BF1 motif, but not a reporter lacking this motif. This is the first demonstration of the interaction of ATF-1 with 5′-regulatory sequences of major histocompatibility complex class I genes.
Allotransplantation of sulphate glucomannan-alginate barium (SGA)-microencapsulated rat islets for the treatment of diabetes mellitus.

Xi Chen,Wei Shao,Ji-Bing Chen,Lei Zhang,Corbascio Matthias,Shi-guang Shan,Zhong-quan Qi

DOI: https://doi.org/10.1080/08820130902984828

2009-01-01

Immunological Investigations

Abstract:To offer a more effective microencapsulation technique of islets for the treatment of diabetes, we have developed a new type of microcapsule comprising sulphate glucomannan- alginate barium (SGA). We compared it with traditional microencapsulated APA (alginate-poly-L-lysine-alginate) and ABa (Ba2+-alginate) microencapsulated islets. These three types of microencapsulated islets were prepared and cultured in vitro and we studied their morphology and activity. To determine their effects on insulin secretion and cytokine production (MCP-1, IL-1, IFN-gamma, TNF-alpha) the islets were transplanted into diabetic rats. There was no difference in the morphologies of the three types of microencapsulated islets or their insulin secretory capacity in vitro. However, the SGA microencapsulated islets had higher activity and produced more insulin than the APA and ABa microencapsulated islets after transplantation. Normoglycemia was maintained for longer in the SGA-transplanted group than in the other two groups. The concentrations of cytokines in the peritoneal fluid were significantly decreased in the SGA group, as was the infiltration of inflammatory cells around the microcapsules. In conclusion, the novel SGA microencapsulated islets can maintain normoglycemia in diabetic rats without immunosuppression for longer than APA and ABa microencapsulated islets.
Probing of New Polymer-Based Microcapsules for Islet Cell Immunoisolation

Polina Ermakova,Ekaterina Vasilchikova,Maxim Baten’kin,Alexandra Bogomolova,Alexey Konev,Natalia Anisimova,Alena Egoshina,Mariya Zakharina,Julia Tselousova,Nasipbek Naraliev,Denis Kuchin,Liya Lugovaya,Vladimir Zagainov,Sergey Chesnokov,Aleksandra Kashina,Elena Zagaynova

DOI: https://doi.org/10.3390/polym16172479

IF: 5

2024-09-03

Polymers

Abstract:Islet allotransplantation offers a promising cell therapy for type 1 diabetes, but challenges such as limited donor availability and immunosuppression persist. Microencapsulation of islets in polymer-coated alginate microcapsules is a favored strategy for immune protection and maintaining islet viability. This study introduces Poly [2-(methacryloyloxy)ethyl]trimethylammonium chloride (PMETAC) as an innovative coating material for microcapsules. PMETAC enhances biocompatibility and durability, marking a significant advancement in islet encapsulation. Our approach combines alginate with PMETAC to create Langerhans islet microcapsules, simplifying material composition and preparation and ultimately lowering costs and increasing clinical applicability. Our comprehensive evaluation of the stability (including osmotic stability, thermal stability, and culture condition stability) and cytotoxicity of a novel microencapsulation system based on alginate-PMETAC-alginate offers insights into its potential application in islet immunoisolation strategies. Microcapsules with PMETAC content ranging from 0.01 to 1% are explored in the current work. The results indicate that the coatings made with 0.4% PMETAC show the most promising outcomes, remaining stable in the mentioned tests and exhibiting the required permeability. It was shown that the islets encapsulated in this manner retain viability and functional activity. Thus, alginate microcapsules coated with 0.4% PMETAC are suitable for further animal trials. While our findings are promising, further studies, including animal testing, will be necessary to evaluate the clinical applicability of our encapsulation method.

polymer science
An investigation of functionalized chitosan and alginate multilayer conformal nanocoating on mouse beta cell spheroids as a model for pancreatic islet transplantation

Michael Y Yitayew,Marco Gasparini,Ling Li,Steven Paraskevas,Maryam Tabrizian

DOI: https://doi.org/10.1016/j.ijbiomac.2024.134960

2024-08-21

Abstract:Multilayer conformal coatings have been shown to provide a nanoscale barrier between cells and their environment with adequate stability, while regulating the diffusion of nutrition and waste across the cell membrane. The coating method aims to minimize capsule thickness and implant volume while reducing the need for immunosuppressive drugs, making it a promising approach for islet cell encapsulation in clinical islet transplantation for the treatment of Type 1 diabetes. This study introduces an immunoprotective nanocoating obtained through electrostatic interaction between quaternized phosphocholine-chitosan (PC-QCH) and tetrahydropyran triazole phenyl-alginate (TZ-AL) onto mouse β-cell spheroids. First, successful synthesis of the proposed polyelectrolytes was confirmed with physico-chemical characterization. A coating with an average thickness of 540 nm was obtained with self-assembly of 4-bilayers of PC-QCH/TZ-AL onto MIN6 β-cell spheroids. Surface coating of spheroids did not affect cell viability, metabolic activity, or insulin secretion, when compared to non-coated spheroids. The exposure of the polyelectrolytes to THP-1 monocyte-derived macrophages lead to a reduced level of TNF-α secretion and exposure of coated spheroids to RAW264.7 macrophages showed a decreasing trend in the secretion of TNF-α and IL-6. In addition, coated spheroids were able to establish normoglycemia when implanted into diabetic NOD-SCID mice, demonstrating in vivo biocompatibility and cellular function. These results demonstrate the ability of the PC-QCH/TZ-AL conformal coating to mitigate pro-inflammatory response from macrophages, and thus can be a promising candidate towards nanoencapsulation for cell-based therapy, particularly in type 1 diabetes, where the insulin secreting β-cells are subjected to inflammation and immune cell attack.
Interpenetrating Network of Alginate–Human Adipose Extracellular Matrix Hydrogel for Islet Cells Encapsulation

Jun Kit Wang,Nicole Mein Ji Cheam,Scott Alexander Irvine,Nguan Soon Tan,Subbu Venkatraman,Chor Yong Tay

DOI: https://doi.org/10.1002/marc.202000275

IF: 5.006

2020-08-19

Macromolecular Rapid Communications

Abstract:<p>Transplantation of microencapsulated islet cells holds great potential for the treatment of type 1 diabetes mellitus. However, its clinical translation is hampered by the peri‐transplantation loss of islet viability and functionality in the microcapsules. In this work, a novel islet cells biomimetic microencapsulant material that is based on the interpenetrating networks of alginate and extracellular matrix (ECM) hydrogel composite (AEC) is presented. The ECM component is derived from human lipoaspirate. In situ encapsulation of pancreatic β islet cells (MIN6 β‐cells) can be achieved via ionotropic gelation of the alginate matrix and thermal‐induced gelation of the pepsin‐solubilized ECM pre‐gel. Due to the enhanced cell–matrix interaction, islets encapsulated within the AEC microcapsules (≈640 µm) display sevenfold increase in cell growth over 1 week of culture and characteristic glucose‐stimulated insulin response in vitro. The results show that the AEC microcapsule is a potent platform to bioaugment the performance of islet cells.</p>

polymer science
Aortopexy for Life-Threatening Airway Obstruction Following Division of Double Aortic Arch

K. Hammond-Jack,K. Ramakrishnan,D. Nath

DOI: https://doi.org/10.1177/2150135117709023

2020-07-01

Abstract:Symptoms of airway compression secondary to double aortic arch are relieved by division of one of the two aortic arches. However, in some cases inherent tracheomalacia and other factors may result in persistence of symptoms. We report one such occurrence in our experience and describe the use of aortopexy as a curative procedure to tackle this problem.
Investigation of the effect of pancreatic decellularized matrix on encapsulated Islets of Langerhans with mesenchymal stem cells

Alparslan Okcu,Yusufhan Yazir,Turgay Şimşek,Serap Mert,Gökhan Duruksu,Ahmet Öztürk,Kamil Can Kiliç,Gürler Akpinar,Murat Kasap

DOI: https://doi.org/10.1016/j.tice.2023.102110

Abstract:Objective: In this study, it was aimed to provide a therapeutic approach for T1DM by encapsulating the pancreatic islets with mesenchymal stem cells and decellularized pancreatic extracellular matrix to support the survival of islets while maintaining their cellular activity. Method: Pancreatic extracellular matrix was decellularized using different concentrations of detergent series. After the preparation of the protein-based tissue extracellular matrix was shown to be free of cells or any genetic material by molecular, immunofluorescence and histochemical techniques. Following the homogenization of the decellularized pancreatic extracellular matrix and the analysis of its protein composition by LC-MS, the matrix proteins were incorporated with pancreatic islets and rat adipose tissue-derived MSCs (rAT-MSCs) in alginate microcapsules. Glucose-stimulated insulin secretion property of the islet cells in the microbeads was evaluated by insulin ELISA. The gene expression profile of the encapsulated cells was analyzed by Real-Time PCR. Results: Unlike the protein composition of whole pancreatic tissue, the decellularized pancreas matrix was free of histone proteins or proteins originated from mitochondria. The protein matrix derived from pancreatic tissue was shown to support the growth and maintenance of the islet cells. When compared to the non-encapsulated pancreatic islet, the encapsulated cells demonstrate to be more efficient in terms of insulin expression. Conclusion: The extracellular pancreatic matrix obtained in this study was directly used as supplementary in the alginate-based microcapsule enhancing the cell survival. The tissue matrix protein and alginate had a synergistic effect on total insulin secretion, which might have the potential to overcome the insulin deficiency. Despite the improvement in the cell viability and the number, the efficiency of the insulin secretion in response to glucose stimulation from the alginate microcapsules did not meet the expectation when compared with the non-encapsulated pancreatic islets.
Porous microcapsules encapsulating β cells generated by microfluidic electrospray technology for diabetes treatment

Xiaoyu Liu,Yunru Yu,Dechen Liu,Jingbo Li,Ji Sun,Qiong Wei,Yuanjin Zhao,S. J. Pandol,Ling Li

DOI: https://doi.org/10.1038/s41427-022-00385-5

IF: 10.761

2022-05-06

NPG Asia Materials

Abstract:Diabetes mellitus is becoming increasingly prevalent worldwide and needs effective clinical treatment methods. β-Cell replacement therapy has become a safe alternative for diabetes treatment in recent years, and encapsulation methods have been proposed to facilitate this type of therapy. Here, we used coaxial microfluidic electrospray technology to generate microcapsules allowing high cell viability (>90%) with porous alginate shells and β cell-containing cores in less than half an hour. Benefitting from microfluidic electrospray, the sizes of the generated microcapsules were adjustable. The biocompatible porous hydrogel shell not only protected β cells from immune rejection but also allowed the exchange of small molecular nutrients during transplantation, and the liquid core guaranteed the high viability of the encapsulated cells. This constructed living cell biosystem further demonstrated its potential as an artificial islet after transplantation into the omental pouches of diabetic mice to control blood glucose levels and thus treat diabetes. We consider that this system, with an elaborate structure and an abundance of highly viable encapsulated β cells to improve treatment performance, could be applied in a wide range of clinical situations.

materials science, multidisciplinary
Characterizing an injectable alginate hydrogel as a co‐encapsulating system for beta cells and curcumin in type 1 diabetes therapy

Parisa Abbasi,Iran Alemzadeh,Manouchehr Vossoughi

DOI: https://doi.org/10.1002/cjce.25288

2024-04-30

The Canadian Journal of Chemical Engineering

Abstract:Overview of hydrogel synthesis, characterization, and encapsulation of cell and curcumin within the hydrogel matrix. Encapsulating insulin‐secreting cells within biocompatible hydrogels is a tissue engineering approach for type 1 diabetes treatment. Macroencapsulation is preferred over other encapsulation methods due to its easy implantation and retrieval. However, this treatment has challenges, including the need for invasive surgery for macrocapsule implantation and host response, resulting in fibrotic overgrowth around the implant and subsequent failure of the graft. Herein, an injectable alginate hydrogel, fabricated by different concentrations of Na2HPO4 as a retarding agent, was applied to avoid surgery. According to characterization tests, hydrogel made by 0.3 M Na2HPO4 showed a higher swelling ratio and diffusion coefficient, appropriate for the diffusion of nutrients, oxygen, and insulin. It was also stiffer with a lower swelling rate, demonstrating more robust elastic and solid‐like behaviour, suitable for cell attachment. Its small pore size (133.04 ± 53.28 μm), additionally, was essential for inhibiting immunoglobulins penetration. Thus, this hydrogel was used for RIN‐5F cells encapsulation and demonstrated good biocompatibility (>88% viability), and maintained the insulin‐releasing function of cells. Afterward, we co‐encapsulated beta cells with curcumin as an anti‐inflammatory drug and investigated the effect of this agent on cell behaviour in vitro. It was indicated that curcumin did not adversely affect viability and insulin secretion.

engineering, chemical
Dedifferentiation of cells: new approaches.

P. Collas

DOI: https://doi.org/10.1080/14653240701218532

IF: 6.196

Cytotherapy

Abstract:Reprogramming of a differentiated cell into a cell capable of giving rise to many different cell types, a pluripotent cell, which in turn could repopulate or repair sick or damaged tissue, would present beneficial applications in regenerative medicine. Somatic cell nuclear transfer may offer this possibility, but technical hurdles and ethical frameworks currently prevent application of this technology in several countries. As a result, alternative strategies to reprogramming cell fate are being developed. This review briefly addresses somatic cell nuclear transfer and focuses on recent non-nuclear transfer-based approaches for reprogramming somatic cells and enhancing their differentiation potential. These include the fusion of somatic cells with embryonic stem cells, the treatment of somatic cells with extract of pluripotent cells and the retroviral transduction of somatic cells to overexpress pluripotency genes.
Biocompatibility of purified sodium alginate-barium chloride microcapsule and functional assessment of transplanted pancreas islet via the microcapsule for type Ⅰ diabetes

Mei Zhang,Chao Liu,Cui-ping Liu,You-wen Qin

DOI: https://doi.org/10.3321/j.issn:1673-8225.2005.07.037

2005-01-01

Abstract:BACKGROUND: Sodium alginate-poly-lysine can cause foreign body reaction to induce functional inactivation of the microencapsulated islets following transplantation. Can barium chloride solve this problem?OBJECTIVE: To assess the biocompat ibility of purified sodium alginate-barium chloride microcapsules and the bioactivity of the microencapsulated islets of rats.DESIGN: A randomized controlled experiments based on the experimental animals.SETTING: Department of endocrinology in a university hospital.MATERIALS: This experiment was completed in the Laboratory of Endocrinology and Department of Laboratory Animals, First Affiliated Hospital of Nanjing Medical University during July to December 2002. Specific pathogen-free SD and Wistar rats were provided by Center of Animal Experiment, Nanjing Medical University and Animal Experiment Center of Shanghai respectively.METHODS: Purified and non-purified sodium alginate-barium chloride microcapsules were prepared with one-step method using domestically made equipment. The microcapsule was transplanted intraperitoneally into normal SD rats and its biocompatibility was observed 4 weeks later. The bioactivity of the microencapsulated islets was also observed following transplantation in streptozotocin(STZ)-induced diabetic Wistar rat models.MAIN OUTCOME MEASURES: ① The recovery rate of the transplanted empty microcapsule; ② Results of bioactivity assessment of the insulin from the microencapsulated islets; ③ Histological examination.RESULTS: Four weeks after the transplantation, the recovery rate of the transplanted empty microcapsules in the purified group was higher that that in non-purified group( P > 0.05), and the purified microcapsules retained intact and smooth morphology with out causing fibrosis. The islets encapsulated by purified sodium alginate-barium chloride microcapsules showed good insulin-ecreting function in in vitro culture, without significant difference from non-microencaps ulated islets( P > 0. 05) . The islets transplanted via the microcapsules into diabetic Wistar rat models induced by STZ had a survival time over 6 weeks.CONCLUSION: The purified sodium alginate-barium chloride microcapsules have good bioactivity and tissue compatibility, which might provide a solution for the source of donor diabetic islets in the treatment of type Ⅰ diabetes.
Alginate–Poly [2-(methacryloyloxy)ethyl]trimethylammonium Chloride (PMETAC) Immunoisolating Capsules Prolong the Viability of Pancreatic Islets In Vivo

Polina Ermakova,Ekaterina Vasilchikova,Arseniy Potapov,Maxim Baten'kin,Liya Lugovaya,Alexandra Bogomolova,Julia Tselousova,Alexey Konev,Natalia Anisimova,Alena Egoshina,Mariya Zakharina,Nasipbek Naraliev,Denis Kuchin,Vladimir Zagainov,Sergey Chesnokov,Aleksandra Kashina,Elena Zagaynova

DOI: https://doi.org/10.3390/biomedicines12112573

IF: 4.757

2024-11-11

Biomedicines

Abstract:Background/Objectives: This study focuses on the development and evaluation of novel alginate–poly [2-(methacryloyloxy)ethyl]trimethylammonium chloride (PMETAC) microcapsules for encapsulating pancreatic islets to address insulin deficiency in diabetes. Methods: In previous research, we fabricated and characterized PMETAC microcapsules, evaluating their stability and permeability in vitro. This study further probes the capsules in vivo, focusing on the functional activity of the encapsulated islets post-transplantation, their viability extension, and the assessment of the immunoprotective, antifibrotic properties, and biostability of the capsules. Results: Rabbit-derived islets were encapsulated and transplanted into diabetic rats. The encapsulated islets maintained insulin secretion for up to 90 days, significantly longer than non-encapsulated ones, which ceased functioning after 7 days. Histological analysis demonstrated high biocompatibility of the PMETAC coating, resulting in minimal fibrotic overgrowth around the capsules. Conclusions: The study highlights the critical role of immunoprotection and the tendency to reduce fibrosis in prolonging islet function. These findings suggest that PMETAC-coated capsules offer a promising solution for cell-based therapies in diabetes by improving graft longevity and reducing fibrotic overgrowth.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
Performance of islets of Langerhans conformally coated via an emulsion cross-linking method in diabetic rodents and nonhuman primates

Aaron A. Stock,Grisell C. Gonzalez,Sophia I. Pete,Teresa De Toni,Dora M. Berman,Alexander Rabassa,Waldo Diaz,James C. Geary,Melissa Willman,Joy M. Jackson,Noa H. DeHaseth,Noel M. Ziebarth,Anthony R. Hogan,Camillo Ricordi,Norma S. Kenyon,Alice A. Tomei

DOI: https://doi.org/10.1126/sciadv.abm3145

IF: 13.6

2022-06-30

Science Advances

Abstract:Polyethylene glycol (PEG)–based conformal coating (CC) encapsulation of transplanted islets is a promising β cell replacement therapy for the treatment of type 1 diabetes without chronic immunosuppression because it minimizes capsule thickness, graft volume, and insulin secretion delay. However, we show here that our original CC method, the direct method, requiring exposure of islets to low pH levels and inclusion of viscosity enhancers during coating, severely affected the viability, scalability, and biocompatibility of CC islets in nonhuman primate preclinical models of type 1 diabetes. We therefore developed and validated in vitro and in vivo, in several small- and large-animal models of type 1 diabetes, an augmented CC method—emulsion method—that achieves hydrogel CCs around islets at physiological pH for improved cytocompatibility, with PEG hydrogels for increased biocompatibility and with fivefold increase in encapsulation throughput for enhanced scalability.

multidisciplinary sciences
Immunoisolation of murine islet allografts in vascularized sites through conformal coating with polyethylene glycol

Vita Manzoli,Chiara Villa,Allison L Bayer,Laura C Morales,R Damaris Molano,Yvan Torrente,Camillo Ricordi,Jeffrey A Hubbell,Alice A Tomei,Allison L. Bayer,Laura C. Morales,R. Damaris Molano,Jeffrey A. Hubbell,Alice A. Tomei

DOI: https://doi.org/10.1111/ajt.14547

IF: 9.369

2017-12-02

American Journal of Transplantation

Abstract:Islet encapsulation may allow transplantation without immunosuppression, but thus far islets in large microcapsules transplanted in the peritoneal cavity have failed to reverse diabetes in humans. We showed that islet transplantation in confined well-vascularized sites like the epididymal fat pad (EFP) improved graft outcomes, but only conformal coated (CC) islets can be implanted in these sites in curative doses. Here, we showed that CC using polyethylene glycol (PEG) and alginate (ALG) was not immunoisolating because of its high permselectivity and strong allogeneic T cell responses. We refined the CC composition and explored PEG and islet-like extracellular matrix (Matrigel; MG) islet encapsulation (PEG MG) to improve capsule immunoisolation by decreasing its permselectivity and immunogenicity while allowing physiological islet function. Although the efficiency of diabetes reversal of allogeneic but not syngeneic CC islets was lower than that of naked islets, we showed that CC (PEG MG) islets from fully MHC-mismatched Balb/c mice supported long-term (>100 days) survival after transplantation into diabetic C57BL/6 recipients in the EFP site (750-1000 islet equivalents/mouse) in the absence of immunosuppression. Lack of immune cell penetration and T cell allogeneic priming was observed. These studies support the use of CC (PEG MG) for islet encapsulation and transplantation in clinically relevant sites without chronic immunosuppression.
Hydrogel injection molded complex macroencapsulation device geometry improves long-term cell therapy viability and function in the rat omentum transplant site

Amy E Emerson,Quincy Lyons,Matthew W. Becker,Keven Sepulveda,Shivani C. Hiremath,Sarah R. Brady,Jessica D Weaver

DOI: https://doi.org/10.1101/2024.08.11.607495

2024-08-12

Abstract:Insulin-secreting allogeneic cell therapies are a promising treatment for type 1 diabetes, with the potential to eliminate hypoglycemia and long-term complications of the disease. However, chronic systemic immunosuppression is necessary to prevent graft rejection, and the acute risks associated with immunosuppression limit the number of patients who can be treated with allogeneic cell therapies. Islet macroencapsulation in a hydrogel biomaterial is one proposed method to reduce or eliminate immune suppression; however, macroencapsulation devices suffer from poor oxygen transport and limited efficacy as they scale to large animal model preclinical studies and clinical trials. Hydrogel geometric device designs that optimize nutrient transport combined with methods to promote localized vasculogenesis may improve in vivo macroencapsulated cell viability and function. Here, we demonstrate with finite element modeling that a high surface area-to-volume ratio spiral geometry can increase macroencapsulated islet viability and function relative to a traditional cylindrical design, and we validate these observations in vitro under normoxic and physiological oxygen conditions. Finally, we evaluate macroencapsulated syngeneic islet survival and function in vivo in a diabetic rat omentum transplant model, and demonstrate that high surface area-to-volume hydrogel device designs improved macroencapsulated syngeneic islet function relative to traditional device designs.

Bioengineering
Islet Encapsulation: New Developments for the Treatment of Type 1 Diabetes

Qi Zhang,Carmen Gonelle-Gispert,Yanjiao Li,Zhen Geng,Sandrine Gerber-Lemaire,Yi Wang,Leo Buhler

DOI: https://doi.org/10.3389/fimmu.2022.869984

IF: 7.3

2022-04-14

Frontiers in Immunology

Abstract:Islet transplantation is a promising approach for the treatment of type 1 diabetes (T1D). Currently, clinical islet transplantation is limited by allo - and autoimmunity that may cause partial or complete loss of islet function within a short period of time, and long-term immunosuppression is required to prevent rejection. Encapsulation into semipermeable biomaterials provides a strategy that allows nutrients, oxygen and secreted hormones to diffuse through the membrane while blocking immune cells and the like out of the capsule, allowing long-term graft survival and avoiding long-term use of immunosuppression. In recent years, a variety of engineering strategies have been developed to improve the composition and properties of encapsulation materials and to explore the clinical practicality of islet cell transplantation from different sources. In particular, the encapsulation of porcine islet and the co-encapsulation of islet cells with other by-standing cells or active ingredients for promoting long-term functionality, attracted significant research efforts. Hydrogels have been widely used for cell encapsulation as well as other therapeutic applications including tissue engineering, cell carriers or drug delivery. Here, we review the current status of various hydrogel biomaterials, natural and synthetic, with particular focus on islet transplantation applications. Natural hydrophilic polymers include polysaccharides (starch, cellulose, alginic acid, hyaluronic acid, chitosan) and peptides (collagen, poly-L-lysine, poly-L-glutamic acid). Synthetic hydrophilic polymers include alcohol, acrylic acid and their derivatives [poly (acrylic acid), poly (methacrylic acid), poly(acrylamide)]. By understanding the advantages and disadvantages of materials from different sources and types, appropriate materials and encapsuling methods can be designed and selected as needed to improve the efficacy and duration of islet. Islet capsule transplantation is emerging as a promising future treatment for T1D.

immunology
Current and Future Perspectives on Alginate Encapsulated Pancreatic Islet

Berit L Strand,Abba E Coron,Gudmund Skjak-Braek

DOI: https://doi.org/10.1002/sctm.16-0116

Abstract:Transplantation of pancreatic islets in immune protective capsules holds the promise as a functional cure for type 1 diabetes, also about 40 years after the first proof of principal study. The concept is simple in using semipermeable capsules that allow the ingress of oxygen and nutrients, but limit the access of the immune system. Encapsulated human islets have been evaluated in four small clinical trials where the procedure has been evaluated as safe, but lacking long-term efficacy. Host reactions toward the biomaterials used in the capsules may be one parameter limiting the long-term function of the graft in humans. The present article briefly discusses important capsule properties such as stability, permeability and biocompatibility, as well as possible strategies to overcome current challenges. Also, recent progress in capsule development as well as the production of insulin-producing cells from human stem cells that gives promising perspectives for the transplantation of encapsulated insulin-producing tissue is briefly discussed. Stem Cells Translational Medicine 2017;6:1053-1058.
Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study

Armin Mooranian,Susbin Raj Wagle,Bozica Kovacevic,Ryu Takechi,John Mamo,Virginie Lam,Gerald F. Watts,Momir Mikov,Svetlana Golocorbin-Kon,Goran Stojanovic,Hesham Al-Sallami,Hani Al-Salami

DOI: https://doi.org/10.1038/s41598-019-53999-1

IF: 4.6

2020-01-09

Scientific Reports

Abstract:Abstract The antilipidemic drug, probucol (PB), has demonstrated potential applications in Type 2 diabetes (T2D) through its protective effects on pancreatic β-cells. PB has poor solubility and bioavailability, and despite attempts to improve its oral delivery, none has shown dramatic improvements in absorption or antidiabetic effects. Preliminary data has shown potential benefits from bile acid co-encapsulation with PB. One bile acid has shown best potential improvement of PB oral delivery (ursodeoxycholic acid, UDCA). This study aimed to examine PB and UDCA microcapsules (with UDCA microcapsules serving as control) in terms of the microcapsules’ morphology, biological effects ex vivo , and their hypoglycemic and antilipidemic and anti-inflammatory effects in vivo . PBUDCA and UDCA microcapsules were examined in vitro (formulation studies), ex vivo and in vivo . PBUDCA microcapsules exerted positive effects on β-cells viability at hyperglycemic state, and brought about hypoglycemic and anti-inflammatory effects on the prediabetic mice. In conclusion, PBUDCA co-encapsulation have showed beneficial therapeutic impact of dual antioxidant-bile acid effects in diabetes treatment.

multidisciplinary sciences
Microfluidic Production of Zwitterion Coating Microcapsules with Low Foreign Body Reactions for Improved Islet Transplantation

Zhisheng Xiao,Ting Wei,Ruiliang Ge,Qiaofeng Li,Bo Liu,Zhaoxin Ji,Linfu Chen,Junjie Zhu,Jingjing Shen,Zhuang Liu,Yueye Huang,Yang Yang,Qian Chen

DOI: https://doi.org/10.1002/smll.202202596

IF: 13.3

2022-06-25

Small

Abstract:Core–shell microcapsules with zwitterionic coatings are fabricated by a designed microfluidic device exhibiting excellent foreign body reaction (FBR)‐mitigating properties and protective effects of islets. After transplantation, such islet‐encapsulated microcapsules can successfully restore the glucose of diabetic mice and maintain their normoglycemia for up to 3 months. Islet transplantation is a promising strategy for type 1 diabetes mellitus (T1DM) treatment, whereas implanted‐associated foreign body reaction (FBR) usually induces the necrosis of transplanted islets and leads to the failure of glycemic control. Benefiting from the excellent anti‐biofouling property of zwitterionic materials and their successful application in macroscopic implanted devices, microcapsules with zwitterionic coatings may be promising candidates for islet encapsulation. Herein, a series of zwitterion‐coated core–shell microcapsules is fabricated (including carboxybetaine methacrylate [CBMA]‐coated gelatin methacrylate [GelMA] [CBMA‐GelMA], sulfobetaine methacrylate [SBMA]‐coated GelMA [SBMA‐GelMA], and phosphorylcholine methacrylate [MPC]‐coated GelMA [MPC‐GelMA]) by one‐step photopolymerization of inner GelMA and outer zwitterionic monomers via a handmade two‐fluid microfluidic device and it is demonstrated that they can effectively prevent protein adsorption, cell adhesion, and inflammation in vitro. Interestingly, the zwitterionic microcapsules successfully resist FBR in C57BL/6 mice after intraperitoneal implantation for up to 4 months. After successfully encapsulating xenogeneic rat islets in the SBMA‐GelMA microcapsules, sustained normoglycemia is further validated in streptozotocin (STZ)‐induced mice for up to 3 months. The zwitterion‐modified microcapsule using a microfluidic device may represent a platform for cell encapsulation treatment for T1DM and other hormone‐deficient diseases.

materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology

Dressed exciton versus dressed atom: The space-dimension dependence.

Nanoporous alumina capsules for cellular macroencapsulation: transport and biocompatibility.

Activation Transcription Factor 1 Involvement in the Regulation of Murine H-2D d Expression*

Allotransplantation of sulphate glucomannan-alginate barium (SGA)-microencapsulated rat islets for the treatment of diabetes mellitus.

Probing of New Polymer-Based Microcapsules for Islet Cell Immunoisolation

An investigation of functionalized chitosan and alginate multilayer conformal nanocoating on mouse beta cell spheroids as a model for pancreatic islet transplantation

Interpenetrating Network of Alginate–Human Adipose Extracellular Matrix Hydrogel for Islet Cells Encapsulation

Aortopexy for Life-Threatening Airway Obstruction Following Division of Double Aortic Arch

Investigation of the effect of pancreatic decellularized matrix on encapsulated Islets of Langerhans with mesenchymal stem cells

Porous microcapsules encapsulating β cells generated by microfluidic electrospray technology for diabetes treatment

Characterizing an injectable alginate hydrogel as a co‐encapsulating system for beta cells and curcumin in type 1 diabetes therapy

Dedifferentiation of cells: new approaches.

Biocompatibility of purified sodium alginate-barium chloride microcapsule and functional assessment of transplanted pancreas islet via the microcapsule for type Ⅰ diabetes

Alginate–Poly [2-(methacryloyloxy)ethyl]trimethylammonium Chloride (PMETAC) Immunoisolating Capsules Prolong the Viability of Pancreatic Islets In Vivo

Performance of islets of Langerhans conformally coated via an emulsion cross-linking method in diabetic rodents and nonhuman primates

Immunoisolation of murine islet allografts in vascularized sites through conformal coating with polyethylene glycol

Hydrogel injection molded complex macroencapsulation device geometry improves long-term cell therapy viability and function in the rat omentum transplant site

Islet Encapsulation: New Developments for the Treatment of Type 1 Diabetes

Current and Future Perspectives on Alginate Encapsulated Pancreatic Islet

Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study

Microfluidic Production of Zwitterion Coating Microcapsules with Low Foreign Body Reactions for Improved Islet Transplantation